![Michael Jacobs](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Michael Jacobs
Direttore/Membro del Consiglio presso Custom Healthcare Ltd.
Profilo
Michael Jacobs has worked as a Director at Custom Healthcare Ltd.
since 2017.
Posizioni attive di Michael Jacobs
Società | Posizione | Inizio |
---|---|---|
Custom Healthcare Ltd.
![]() Custom Healthcare Ltd. Pharmaceuticals: MajorHealth Technology Part of Cheremy Capital LLC, Custom Healthcare Ltd. is a pharmaceutical contract development and manufacturing organization (CDMO). Founded in 2001 and based in Hove, UK, the company covers the full spectrum of activities from process development through commercial manufacturing. The British company offers a wide range of industry-leading pharmaceutical CDMO services, from clinical to commercial, and are capable of taking compounds from clinical to commercial. Custom Healthcare holds licenses issued by the MHRA, including MIA, MIA(IMP), MS, WDA, and controlled drugs licenses (schedules II – V). The company's project management team ensures that a multidisciplinary team supports each project to deliver with excellence. | Direttore/Membro del Consiglio | 26/09/2017 |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 1 |
---|---|
Custom Healthcare Ltd.
![]() Custom Healthcare Ltd. Pharmaceuticals: MajorHealth Technology Part of Cheremy Capital LLC, Custom Healthcare Ltd. is a pharmaceutical contract development and manufacturing organization (CDMO). Founded in 2001 and based in Hove, UK, the company covers the full spectrum of activities from process development through commercial manufacturing. The British company offers a wide range of industry-leading pharmaceutical CDMO services, from clinical to commercial, and are capable of taking compounds from clinical to commercial. Custom Healthcare holds licenses issued by the MHRA, including MIA, MIA(IMP), MS, WDA, and controlled drugs licenses (schedules II – V). The company's project management team ensures that a multidisciplinary team supports each project to deliver with excellence. | Health Technology |
- Borsa valori
- Insiders
- Michael Jacobs